Hyderabad: Breast cancer is the most common type of cancer among Indian females with age adjusted rate as high as 25.8 per 100,000 women and mortality 12.7 per 100,000 women. There are multiple reasons for late detection including lack of awareness, shyness on part of patients, social stigma, and ignorance at primary and secondary health care level. Early detection is best choice for reducing mortality.
In India, burden of breast cancer is increasing due to various factors and more young women reported diagnosed at advanced stage. An early diagnosis and treating identified patients with appropriate medical management improves the treatment outcome and quality of life and decrease the burden for the patient and the dependent. Current innovative treatment options offers to extend the life of advanced breast cancer patients with acceptable quality of life.
Telangana Regional Round Table meeting on Breast Cancer was organized by Confederation of Indian Industry (CII) in partnership with Novartis today
Dr Dinesh Pendharkar, President of Indian Society of Oncology said that Cancer units at district level is working in 7 states already and will be initiated soon in Telangana.
Ms Uma Aysola, IWN -Telangana & Head, Alliances & Partnerships, Access Health International Inc said that we are certain that we will be able to come up with novel collaborative model of combating this deadly disease by including all the relevant stakeholders in the healthcare system.
Dr Netagani Jayalatha, Director, MNJ Institute of Oncology Regional Cancer mentioned that incidence of early breast cancer is increasing by 2 percent every year. Only 2.4 percent of all breast cancer cases reported at Regional Cancer Centres (RCCs) are of stage I. More than 50% of the cases are reported at an advanced stage.
Prabhat Kumar Sinha, Head Patient Advocacy, Policy and Communication Novartis mentioned that Novartis is working with 7 states for public Health Initiatives through formal MOUs and is committed to improve health outcome for breast cancer patients.
The objective of the state round table was to capture insights and suggestions from various stakeholders at state level and collate it along with some of the good practices in form of a white paper. The stakeholders included government representatives, medical colleges, hospitals, academia and civil society organisations.